Boston puts brave face on cardiac meltdown
This article was originally published in Clinica
Executive Summary
Boston Scientific, beset with uncertainty over its attempt to buy out Medinol and still recovering from two years of accounting irregularities, product recalls, adverse incidents and a lost legal battle with Johnson & Johnson, has reported dramatically slumping sales for last year. The damage, which accelerated in the fourth quarter, is located in its Scimed cardiology division.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.